Pharmaceutical Care Management Association President and CEO JC Scott said drugmaker rebates negotiated by pharmacy benefit managers offset high prices and stabilize premiums for Medicaid and Medicare beneficiaries. Proposals to restrict negotiated price concessions "would enrich drugmakers at the expense of patients, who'd face higher premiums and out-of-pocket costs. ... [And] would do nothing to reduce drug prices," Scott said.
Community pharmacies that are not recouping drug costs should find a new pharmacy services administration organization, says Pharmaceutical Care Management Association Senior Director of State Affairs Scott Woods. PCMA spokesman Greg Lopes said, "PBMs' job is to reduce the cost of prescriptions for their clients and the consumer as well increase access to medications."
Sen. Bernie Sanders, I-Vt., and Rep. Elijah Cummings, D-Md., introduced legislation consisting of three measures intended to lower US drug prices. The bill would tie US drug prices to the median price from Japan, Canada, France, Britain and Germany; permit HHS to negotiate prices in Medicare Part D; and allow Americans to purchase cheaper drugs from Canada and other countries.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications